HCA today
$500.66-$5.38 (-1.06%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourBearish
15 minBearish
5 minConsolidating
Daily trend turns down below $439.83
Key levels
Resistance$556.52
Resistance$521.48
Support$488.00
Support$465.31
Latest news & SEC filings
NewsHCA Healthcare says its in-house radiology AI is lifting productivity
AnalystMizuho raises HCA Healthcare price target to $570 from $495
NewsHCA Healthcare executive sells company stock in insider transaction
All HCA news →About HCA Healthcare
HCA Healthcare operates general acute care hospitals, behavioral hospitals, and rehabilitation hospitals, along with freestanding ambulatory surgery and endoscopy centers. Its hospitals offer medical and surgical services including internal medicine, cardiology, oncology, orthopedics, and obstetrics, plus diagnostic and emergency care. Patients include Medicare and Medicaid beneficiaries, managed care and private insurance enrollees, and uninsured individuals. Facilities are located across 19 U.S. states and in England.
Based on the company's 10-K filed Feb 10, 2026.
NYSE · Healthcare
HCA Healthcare, Inc. (HCA)
What Is the Price Target for HCA?
SEPT Low Target
$380.00
SEPT Mid Target
$485.00
SEPT High Target
$579.00
Analyst Consensus
$485.00
Is HCA a Buy or Sell Right Now?
Thesis
- •Revenue growing 7.1% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 2 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HCA.
Start Free Trial →Is HCA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG, Analyst Consensus
Fair Value
$560.40
20
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with HCA?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
BUYING
5 buys / 4 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Rossitto Erica | officer | Sale | 3,500 | $1.8M | Nov 10, 2026 |
| Foster Jon M | officer | Sale | 890 | $444K | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 1,684 | $839K | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 1,066 | $530K | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 2,692 | $1.3M | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 7,595 | $3.8M | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 6,302 | $3.1M | Nov 6, 2026 |
| Foster Jon M | officer | Sale | 1,484 | $730K | Nov 6, 2026 |
| Rossitto Erica | officer | Buy | 8,080 | $662K | Nov 6, 2026 |
| Rossitto Erica | officer | Buy | 5,040 | $510K | Nov 6, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HCA Growth Story
Revenue YoY
7.1%
3yr Revenue CAGR
7.9%
EPS Growth YoY
28.77%
FCF Growth YoY
36.4%
Revenue Trend
STABLE
Dark Pool Trades for HCA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HCA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:58:55 | $500.66 | 3,930 | $$2.0M | SELL |
| 21:23:33 | $500.66 | 1,105 | $$553K | SELL |
| 21:00:49 | $500.66 | 1,020 | $$511K | SELL |
| 21:00:49 | $500.66 | 1,521 | $$762K | SELL |
| 21:00:49 | $500.66 | 1,020 | $$511K | SELL |
5 dark pool trades shown · $$4.3M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for HCA
PREVIEWSEPT Investing provides real-time options flow tracking for HCA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $240 | Jan 15 | 64 | $$54.5K | 2 | REGULAR |
| CALL | $160 | Dec 18 | 36 | $$175.9K | 5 | REGULAR |
| CALL | $155 | Dec 18 | 36 | $$71.3K | 2 | SWEEP |
| CALL | $160 | Dec 18 | 36 | $$140.7K | 4 | REGULAR |
| CALL | $155 | Dec 18 | 36 | $$35.6K | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for HCA Healthcare, Inc. (HCA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HCA — frequently asked questions
What is HCA stock price today?
HCA Healthcare, Inc. (HCA) is at $500.66, down 1.06% (-$5.38) at the Nov 12, 2026 close.
Why is HCA stock moving today?
Latest HCA news — Nov 11, 2026: HCA Healthcare says its in-house radiology AI is lifting productivity · Nov 11, 2026: Mizuho raises HCA Healthcare price target to $570 from $495
Why did HCA stock move on Oct 27, 2026?
HCA Healthcare reported third-quarter 2026 adjusted earnings and revenue that both topped analyst estimates, and management raised its full-year 2026 EPS guidance to $29.60–$30.50 with sales now seen at $78.250B–$79.500B. Despite the bullish results and outlook, the stock fell sharply, closing at $449.96, down 6.26% from the open of $480.00, with a wide range between $488.00 and $439.83 on volume of about 2.86 million shares.
What is the HCA price target?
The average analyst price target for HCA is $485.00, ranging from $380 to $579, based on 17 analysts. Latest: Bernstein raises on Nov 4, 2026.
What do analysts rate HCA?
Analyst ratings for HCA: 0 Buy, 37 Hold, 2 Sell — consensus Hold.
Did HCA beat earnings?
HCA last reported on Oct 27, 2026: EPS $7.27 vs $6.65 expected — a beat of 9.3%.
What is HCA's P/E ratio?
HCA trades at a P/E of 16.7 vs a Healthcare average of 17.2.
Does HCA pay a dividend?
Yes. HCA's dividend yield is 0.63%.
How much debt does HCA have?
HCA Healthcare, Inc. reported $44.8B of debt and $908M of cash (Sep 30, 2026).
What are HCA support and resistance levels?
Support: $488.00, $465.31, $439.83. Resistance: $521.48, $556.52.
What are insiders doing with HCA?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on HCA?
Nov 11, 2026: HCA Healthcare says its in-house radiology AI is lifting productivity · Nov 11, 2026: Mizuho raises HCA Healthcare price target to $570 from $495 · Nov 10, 2026: HCA Healthcare executive sells company stock in insider transaction